For the full year 2023, the Company expects total operating expenses to be between $84.0 million and $88.0 million.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on STIM:
- Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results
- Neuronetics Announces TMS Coverage Criteria Changes for Over 23 Million Covered Lives
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Neuronetics expands NeuroStar Advanced Therapy’s TrakStar platform
- Neuronetics Expands NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform